SCHEMBL28761007

SCHEMBL28761007

[CH2]Cc1cn2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(OC(F)(F)F)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 8/20 0.45
AURKB Q96GD4 5/20 0.45
FLT3 P36888 4/20 0.45
NTRK1 P04629 2/20 0.45
LCK P06239 2/20 0.45
FYN P06241 2/20 0.45
LYN P07948 2/20 0.45
PIM1 P11309 2/20 0.45
MARK3 P27448 2/20 0.45
MAPK9 P45984 2/20 0.45
GSK3A P49840 2/20 0.45
GSK3B P49841 2/20 0.45
BLK P51451 2/20 0.45
RPS6KA3 P51812 2/20 0.45
STK3 Q13188 2/20 0.45
ROCK1 Q13464 2/20 0.45
ERBB4 Q15303 2/20 0.45
NTRK2 Q16620 2/20 0.45
MARK2 Q7KZI7 2/20 0.45
IRAK4 Q9NWZ3 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27682773 0.92 EPHX2 (0.46) KDRAURKBFLT3NTRK1LCK
SCHEMBL13463238 0.90 KDR (0.47) KDRAURKBFLT3NTRK1LCK
SCHEMBL27663144 0.88 TEK (0.53) KDRAURKBFLT3NTRK1LCK
SCHEMBL27663171 0.87 KDR (0.53) KDRAURKBFLT3NTRK1LCK
SCHEMBL27663240 0.87 KDR (0.48) KDRAURKBFLT3NTRK1LCK
SCHEMBL13437469 0.86 KDR (0.51) KDRAURKBFLT3NTRK1LCK
SCHEMBL3620355 0.86 KDR (0.45) KDRAURKBFLT3NTRK1LCK
SCHEMBL3621931 0.85 AURKB (0.49) KDRAURKBFLT3NTRK1LCK
SCHEMBL3612230 0.84 AURKB (0.48) KDRAURKBFLT3NTRK1LCK
SCHEMBL27682735 0.83 KDR (0.49) KDRAURKBFLT3NTRK1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1993361-B Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER PHARMACEUTICALS CORP 2010-05-26 CN disclosed
CN-1993361-A Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER PHARMACEUTICALS CORP (US) 2007-07-04 CN disclosed